The peroxisome proliferator-activated receptor gamma (PPARgamma) is highly expressed in human heart ventricles (Q44223238)

1 December 2017

title

The peroxisome proliferator-activated receptor gamma (PPARgamma) is highly expressed in human heart ventricles (English)

1 reference

1 December 2017

Mohammad R Mehrabi

1

1 reference

1 December 2017

Theresia Thalhammer

2

1 reference

1 December 2017

Petra Haslmayer

3

1 reference

1 December 2017

Helmut D Glogar

4

1 reference

1 December 2017

Georg Wieselthaler

5

1 reference

1 December 2017

Susanne Humpeler

6

1 reference

1 December 2017

Wolfgang Marktl

7

1 reference

1 December 2017

Cem Ekmekcioglu

8

1 reference

1 December 2017

language of work or name

1 reference

1 October 2002

1 reference

Biomedicine and Pharmacotherapy

1 December 2017

published in

1 reference

1 December 2017

volume

56

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

407-410

1 reference

Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Troglitazone does not initiate hypertrophy but can sensitise cardiomyocytes to growth effects of serum

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

24h variation in the expression of the mt1 melatonin receptor subtype in coronary arteries derived from patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

The roles of PPARs in adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

PPARgamma and atherosclerosis: effects on cell growth and movement

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2802%2900251-2

7 January 2021

10.1016/S0753-3322(02)00251-2

Identifiers

DOI

1 reference

1 December 2017

1 reference